( NewsNation) — Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Me, a pioneer in genetic testing, struggles to maintain its early success. As quickly as it soared, its market value ...

o. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered ...

Me is to cut 200 jobs in the wake of declining revenues. This company expects a proposed retructuring, affecting 40% of its ...

What is the most Silicon Valley thing about your morning routine? Zoë, you go first. Zoë Schiffer: Pretty much the first ...

23andMe, the struggling ancestry tracing company, continues to spiral, raising questions about its business prospects and what could happen to its sensitive customer genetic testing data. CEO Anne ...

Medicine is on the precipice of radical changes in diagnosis, personalised treatment, and the ability to prevent disease ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

Virtue-signaling liberals, such as Democratic Sen. Elizabeth Warren of Massachusetts, have a unique capacity for dishonesty.

According to Research by , Rising Demand for Personalized Health Solutions and Proactive Health Management Drives Robust Growth in Predictive Genetic Testing MarketAustin, Nov. 14, 2024 (GLOBE ...

Last June marked four years since the release of Deloitte Canada's inaugural Reconciliation Action Plan (RAP), the first ...